{"id":"W3008866163","doi":"10.1200/jco.2020.38.6_suppl.122","title":"Phase Ib study of niraparib plus androgen receptor-targeted therapy (ART) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Janssen Research and Development","keywords":"Medicine; Prostate cancer; Internal medicine; Cohort; Enzalutamide; Discontinuation; Abiraterone acetate; Neutropenia; Gastroenterology; Cancer; Androgen deprivation therapy; Urology; Oncology; Androgen receptor; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008683268,0.001276659,0.001772877,0.0003312,0.0003617123,0.0009040285,0.0008494181,0.0008698924,0.004747236],"category_scores_gemma":[0.0005832212,0.0006157767,0.0009324561,0.000468331,0.0005610323,0.0006150819,0.000320363,0.002486798,0.00133874],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00078889,"about_ca_system_score_gemma":0.001753282,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001043745,"about_ca_topic_score_gemma":0.00257106,"domain_scores_codex":[0.9996701,0.0001657322,0.00001775474,0.00005562431,0.00002918264,0.00006150682],"domain_scores_gemma":[0.999585,0.00004374532,0.00007193027,0.00003317037,0.00002274348,0.0002433462],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7120454,0.09659693,0.007222441,0.001340598,0.00106865,0.0004724441,0.0003053048,0.004064656,0.05008643,0.0003087255,0.0057565,0.1207319],"study_design_scores_gemma":[0.459751,0.5199791,0.0112304,0.00005550043,0.0003160405,0.0006291273,0.00005706388,0.001227581,0.002686189,0.0002416056,0.003798035,0.00002834404],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9859954,0.002732779,0.000709622,0.0005202605,0.0001781248,0.00388979,0.002088493,0.0001729749,0.003712601],"genre_scores_gemma":[0.9840533,0.002242824,0.001699884,0.001014596,0.000189221,0.003321916,0.004056678,0.00004130754,0.003380359],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004747236,"threshold_uncertainty_score":0.01588112,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1771870291334444,"score_gpt":0.491506432665014,"score_spread":0.3143194035315696,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}